Using this process, 23andMe scientists and research collaborators have published over 300 studies and white papers spanning many topics in health and population genetics, with the average participant contributing to over 200 research papers
By securing global oral capacity now, Novo is shaping the next phase of GLP1 adoption where the real competition may be injection vs pill, and the winner is the one who can deliver at scale
Pretreatment with intravenous CoQ10 (5 mg/kg) reduced serum ALT and markers of oxidative stress, but had no effect on liver glutathione levels (Amimoto 1995)
Because GLP-1s reduce appetite, many have speculated that they will change our fundamental relationship with food, leading consumers to see eating in terms of getting nutrients into the body rather than pleasure from the food itself
Kazakova TB, Barabanova SV, Khavinson VKh, Glushikhina MS, Parkhomenko EP, Malinin VV, et al
Peterson ML, Ma C, Spear BT